Nepsone
Intro
Nepsone is a preclinical-stage pharmaceutical company developing drugs to treat dermatological conditions that arise due to an imbalance in the autonomic nervous system.
Currently, these conditions are believed to originate in the immune system. Nepsone foundational neuroimmunology theory on the origin of psoriasis teaches us that an imbalance in neuropeptide activity in the body leads to these conditions.
Our drugs are designed to utilize the body’s natural mechanisms to bring back balance and alleviate the disease.
Technology Development Fund (Rannís)
Nepsone ehf has been awarded a grant from Tækniþróunarsjóður (Technology Development Fund) of Rannís (The Icelandic Centre for Research).
The People of Nepsone
Stefan Jokull Sveinsson
CEO, M.Sc
Svandis Kristjansdottir
Head of R&D Quality, M.Sc
Morten Fjordholt
CDO, M.Sc
Sigurdur Berntsson
CFO, Cand. Oecon
Gunhild L Skovgaard
Head of Clinical R&D, MD
Jon Petur Joelsson
Head of R&D, PhD
Hakon Hrafn Sigurdsson
R&D Consultant, PhD
Tomas Thorvaldsson
Chairman of the Board
Birkir Sveinsson
Founder / Member of the Board
Ragnar Bjarnason
Member of the Board
Gisli E. Haraldsson MD
Member of the Board
Contact Us
- Nepsone ehf.
- Fiskislod 37b
- 101 Reykjavik
- Iceland
+354 555 1634, +354 840 3332